Could a diabetes drug boost rectal cancer treatment?
Disease control
Not yet recruiting
This study tests whether adding a GLP-1 weight-loss drug (like semaglutide) to standard chemo-radiation before surgery helps rectal cancer patients with a high BMI. Researchers will measure weight loss, tumor response, and survival in 42 participants. The goal is to see if the dr…
Phase: PHASE2 • Sponsor: St. James's Hospital, Ireland • Aim: Disease control
Last updated May 13, 2026 16:02 UTC